Mobius Life Sciences

mobius-portfolio

Portfolio

Mobius Life Sciences' Investments

Xenogesis

XenoGesis Ltd. is a laboratory-based contract research organisation (CRO) specialised in preclinical drug metabolism &...

Keep Reading...

Cellaura Technologies

CellAura Technologies is the premier source of innovative fluorescent screening products for life science research...

Keep Reading...

Haemostatix

Haemostatix is developing first-in-class clotting agents for the treatment of bleeding or ‘haemostasis’. The company...

Keep Reading...

Compandx

CompanDX

CompanDX is at the leading edge of biomarker discovery, utilising advanced mass spectrometry techniques combined...

Keep Reading...

R5 Pharmaceuticals

R5 Pharmaceuticals

BioCity Nottingham also invested in R5 Pharmaceuticals and the company was subsequently sold
© Mobius Life Sciences 2012 Web site design by OLIK